Afya (NASDAQ:AFYA) VP Sells $148,000.00 in Stock

Afya Limited (NASDAQ:AFYA) VP Gomiero Mirella Basolli sold 10,000 shares of Afya stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $14.80, for a total value of $148,000.00. Following the transaction, the vice president directly owned 34,530 shares of the company’s stock, valued at $511,044. The trade was a 22.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Afya Price Performance

Shares of AFYA traded down $0.03 during midday trading on Tuesday, hitting $14.84. 109,181 shares of the company traded hands, compared to its average volume of 105,793. Afya Limited has a one year low of $13.00 and a one year high of $18.16. The firm has a market cap of $1.39 billion, a P/E ratio of 9.70, a PEG ratio of 1.53 and a beta of 0.34. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a 50-day moving average of $14.33 and a 200-day moving average of $14.52.

Hedge Funds Weigh In On Afya

A number of institutional investors have recently made changes to their positions in AFYA. Daiwa Securities Group Inc. purchased a new stake in shares of Afya during the 4th quarter valued at $43,000. Militia Capital Partners LP bought a new stake in shares of Afya during the 2nd quarter worth $71,000. Quantbot Technologies LP purchased a new position in Afya in the second quarter worth $117,000. Van ECK Associates Corp grew its position in Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after acquiring an additional 1,377 shares in the last quarter. Finally, State of Wyoming bought a new position in Afya in the second quarter valued at $164,000. Institutional investors own 88.02% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Bank of America reiterated a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 2nd. JPMorgan Chase & Co. lowered their price objective on Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research report on Monday, June 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. Finally, Zacks Research cut Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.10.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.